Metyrapone from Japan
Metyrapone, containing a methyl 1-(2-pyridyl)-1-propanone structure, inhibits cortisol synthesis in Cushing's syndrome treatment. HTS 2933.39.41.00 applies for its pyridine ring as a drug per Chapter 29 heterocyclic rules. Pharmaceutical bulk powder for API synthesis.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Ketone functionality confirmation via IR spectroscopy supporting pyridine classification
• Specify diagnostic/therapeutic end-use to avoid research chemical reclassification
• Light-sensitive powder; transport in amber containers with stability data